Ablative thyroid treatment for thyrotoxicosis due to thyrotropin-producing pituitary tumours
暂无分享,去创建一个
[1] P. Chanson,et al. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. , 2001, The Journal of clinical endocrinology and metabolism.
[2] R. Smallridge,et al. Treatment of a thyrotropinoma with octreotide-LAR in a patient with multiple endocrine neoplasia-1. , 2000, Thyroid : official journal of the American Thyroid Association.
[3] P. Chanson,et al. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. , 2000, The Journal of clinical endocrinology and metabolism.
[4] J. Doppman,et al. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. , 1999, The Journal of clinical endocrinology and metabolism.
[5] P. Chanson,et al. Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas. , 1994, European Journal of Endocrinology.
[6] J. Kuhn,et al. Effects of a slow‐release formulation of the new somatostatin analogue lanreotide in TSH‐secreting pituitary adenomas , 1994, Clinical endocrinology.
[7] S. Atkin,et al. Hyperthyroidism secondary to a pituitary adenoma secreting TSH, FSH, alpha‐subunit and GH , 1994, Clinical endocrinology.
[8] P. Chanson,et al. Octreotide Therapy for Thyroid-Stimulating Hormone-Secreting Pituitary Adenomas: A Follow-up of 52 Patients , 1993, Annals of Internal Medicine.
[9] V. Sarapura,et al. Effect of thyroid hormone on T3-receptor mRNA levels and growth of thyrotropic tumors , 1993, Molecular and Cellular Endocrinology.
[10] A. Pinchera,et al. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. , 1989, The Journal of clinical endocrinology and metabolism.
[11] F. Brucker-Davis,et al. Thyrotropin-secreting pituitary tumors. , 1996, Endocrinology and metabolism clinics of North America.
[12] B. Weintraub,et al. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. , 1987, The New England journal of medicine.
[13] B. Weintraub,et al. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies. , 1984, The Journal of clinical endocrinology and metabolism.
[14] E. Krenning,et al. Regulation of hormone release by cultured cells from a thyrotropin-growth hormone-secreting pituitary tumor. Direct inhibiting effects of 3, 5, 3′-triiodothyronine and dexamethasone on thyrotropin secretion , 1984, Journal of endocrinological investigation.
[15] D. Aron,et al. TSH and TSH-subunit production by human thyrotrophic tumour cells in monolayer culture. , 1982, Acta endocrinologica.